alexa Determining the Optimal Numbers of Cores Based on Tissu
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Determining the Optimal Numbers of Cores Based on Tissue Microarray Antibody Assessment in Non-Small Cell Lung Cancer

Jason A. Wampfler1, Marie Christine Aubry2, Ping Yang1*, Darren L. Riehle3, C. Dilara Savci-Heijink3, Sumithra Mandrekar4 and Wilma L. Lingle2

1Department of Health Sciences Research, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, Minnesota, 55905, USA

2Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, Minnesota, 55905, USA

3Advanced Genomics Technology Center, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, Minnesota, 55905, USA

4Cancer Center Statistics, Mayo Clinic of College Medicine, 200 First Street SW, Rochester, Minnesota, 55905, USA

*Corresponding Author:
Dr. Ping Yang
Mayo Clinic, 200 First Street SW, Rochester, MN, 55905
Tel: 507-266-5369
Fax: 507-266-2478
E-mail: [email protected]

Received Date: April 23, 2011; Accepted Date: July 20, 2011; Published Date: July 22, 2011

Citation: Wampfler JA, Aubry MC, Yang P, Riehle DL, Savci-Heijink CD (2011) Determining the Optimal Numbers of Cores Based on Tissue Microarray Antibody Assessment in Non-Small Cell Lung Cancer. J Cancer Sci Ther 3:120-124. doi: 10.4172/1948-5956.1000072

Copyright: © 2011 Wampfler JA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Background: Tissue microarrays (TMAs) have been commonly utilized in translational research to rapidly screen numerous biomarkers in large samples. One major concern has been the adequate assessment of biomarkers affected by within-tumor heterogeneity and by molecular targets. Methods: Our study was designed to answer a fundamental question: How do researchers define the optimal cores to sample when designing a TMA study to minimize sampling bias and core artifact? We compared the staining results from a full-section tissue slide to the virtual TMA and from the actual TMA to the virtual TMA. Results: Three cores were demonstrated as optimal for markers such as TTF-1 and p53, but no optimal core number could be determined for markers such as Ki-67 due to the poor TMA representation of the entire tissue. Conclusion: We propose that before using TMAs to analyze large samples, particularly with significant withinsample heterogeneity, a preliminary investigation using a virtual TMA could help decide target markers to be tested for valid and valued results.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords